Company news

GSK plc news in 2021

GSK plc's news releases, calls and decks from 2021, newest first.

View company

ViiV Healthcare announces FDA approval of Apretude

December 21, 2021

Consumer Healthcare Chair Designate appointed

December 20, 2021

Xevudy approved in Europe to treat COVID-19

December 17, 2021

GSK/Sanofi COVID-19 vaccine booster & Ph3 update

December 15, 2021

Medicago/GSK COVID-19 vaccine positive Ph3 data

December 7, 2021

Sotrovimab retains its activity vs Omicron variant

December 7, 2021

GSK publishes provisional 2022 dividend dates

November 24, 2021

Nucala approved in Europe for more indications

November 17, 2021

Phase III IM administration data for sotrovimab

November 12, 2021

GSK shares positive Phase III data for daprodustat

November 5, 2021

SK bio & GSK start Ph3 Covid-19 vaccine trial

August 31, 2021

Director/PDMR Shareholding - amendment

August 13, 2021

CEO Designate of new Consumer Healthcare company

July 22, 2021

GSK announces daprodustat phase 3 headline results

July 16, 2021

GSK and Alector collaboration in immuno-neurology

July 2, 2021

Elliott Advisors (UK) letter to GSK

July 2, 2021

GSK to deliver step-change in growth & performance

June 23, 2021

ViiV/Halozyme sign exclusive licensing agreement

June 22, 2021

GSK and iTeos announce collaboration for EOS-448

June 14, 2021

GSK recommend ADR holders reject mini-tender offer

June 4, 2021

Sanofi and GSK initiate new Phase 3 clinical study

May 27, 2021

GSK/Vir Sotrovimab FDA Emergency Use Authorization

May 27, 2021

GSK/VIR sotrovimab receives positive EMA opinion

May 21, 2021

Medicago/GSK COVID-19 Vaccine Positive Ph2 Results

May 18, 2021

Sanofi/GSK COVID-19 Vaccine Positive Ph2 Results

May 17, 2021

EMTN Prospectus

May 11, 2021

Calls in 2021

Decks in 2021